These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3736043)

  • 41. Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease.
    McQuarrie EP; Freel EM; Mark PB; Fraser R; Connell JM; Jardine AG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1526-32. PubMed ID: 23413088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of linoleic acid hydroperoxide reaction with alkali.
    Gardner HW; Simpson TD; Hamberg M
    Lipids; 1996 Oct; 31(10):1023-8. PubMed ID: 8898300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aldosterone esters and the heart.
    Gomez-Sanchez CE; Foecking MF; Gomez-Sanchez EP
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):200S-205S. PubMed ID: 11411757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and mass spectrometric analysis of hexahydrogenated products of aldosterone, 18-hydroxycorticosterone and 18-hydroxy-11-deoxycorticosterone.
    Bournot P; Maume BF; Padieu P
    J Steroid Biochem; 1981 Nov; 14(11):1127-37. PubMed ID: 7311526
    [No Abstract]   [Full Text] [Related]  

  • 45. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
    Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
    Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone.
    Bamberg K; William-Olsson L; Johansson U; Jansson-Löfmark R; Hartleib-Geschwindner J
    J Renin Angiotensin Aldosterone Syst; 2019; 20(1):1470320319827449. PubMed ID: 30813831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The action of aldosterone on sodium transport: further studies with inhibitors of RNA and protein synthesis.
    Lahav M; Dietz T; Edelman IS
    Endocrinology; 1973 Jun; 92(6):1685-99. PubMed ID: 4707262
    [No Abstract]   [Full Text] [Related]  

  • 48. Synthesis of 21-hydroxy-11,19-oxidopregn-4-ene-3,20-dione and 21-hydroxy-6,19-oxidopregn-4-ene-3,20-dione.
    Veleiro AS; Nevado MV; Monteserín MC; Burton G
    Steroids; 1995 Mar; 60(3):268-71. PubMed ID: 7792830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antinatriuretic and kaliuretic activities of the reduced derivatives of aldosterone.
    Kenyon CJ; Brem AS; McDermott MJ; Deconti GA; Latif SA; Morris DJ
    Endocrinology; 1983 May; 112(5):1852-6. PubMed ID: 6403339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Periodate oxidation products of hydroxylysine in the synthesis of 5-substituted prolines.
    Wu GY; Seifter S
    Anal Biochem; 1985 May; 147(1):103-7. PubMed ID: 2992312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Total Synthesis of Natural PI-091, a New Platelet Aggregation Inhibitor of Microbial Origin.
    Shiraki R; Sumino A; Tadano Ki KI; Ogawa S
    J Org Chem; 1996 Apr; 61(8):2845-2852. PubMed ID: 11667121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progestogens with antimineralocorticoid activity.
    Losert W; Casals-Stenzel J; Buse M
    Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Derivatives of 1,5-diamino-1H-tetrazole: a new family of energetic heterocyclic-based salts.
    Gálvez-Ruiz JC; Holl G; Karaghiosoff K; Klapötke TM; Löhnwitz K; Mayer P; Nöth H; Polborn K; Rohbogner CJ; Suter M; Weigand JJ
    Inorg Chem; 2005 Jun; 44(12):4237-53. PubMed ID: 15934752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of mineralocorticoids on Na+ and K+ excretion in the adrenalectomized rat.
    Horisberger JD; Diezi J
    Am J Physiol; 1983 Jul; 245(1):F89-99. PubMed ID: 6869541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aldosterone antagonists. 1. Synthesis and biological activities of 11 beta,18-epoxypregnane derivatives.
    Kamata S; Haga N; Mitsugi T; Kondo E; Nagata W; Nakamura M; Miyata K; Odaguchi K; Shimizu T; Kawabata T
    J Med Chem; 1985 Apr; 28(4):428-33. PubMed ID: 2984418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemoselective alcoholysis/acetolysis of trans-ketals over cis-ketals and its application in the total synthesis of the cellular second messenger, D-myo-inositol-1,4,5-trisphosphate.
    Vidyasagar A; Pathigoolla A; Sureshan KM
    Org Biomol Chem; 2013 Sep; 11(33):5443-53. PubMed ID: 23851711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells.
    Wehling M; Neylon CB; Fullerton M; Bobik A; Funder JW
    Circ Res; 1995 Jun; 76(6):973-9. PubMed ID: 7758168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 19-Nor deoxycorticosterone (19-nor DOC): mineralocorticoid receptor affinity higher than aldosterone, electrolyte activity lower.
    Funder JW; Mercer J; Ingram B; Feldman D; Wynne K; Adam WR
    Endocrinology; 1978 Oct; 103(4):1514-7. PubMed ID: 744165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 19-Oxo-deoxycorticosterone binds to the renal mineralocorticoid receptor and produces sodium retention but not potassium excretion.
    Thomas CJ; Gomez-Sanchez CE; Marver D; Gomez-Sanchez EP
    Endocrinology; 1983 Aug; 113(2):517-22. PubMed ID: 6307643
    [No Abstract]   [Full Text] [Related]  

  • 60. Phospholipase A and the mechanism of action of aldosterone.
    Yorio T; Bentley PJ
    Nature; 1978 Jan; 271(5640):79-81. PubMed ID: 415245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.